Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: addendum: medication change discharge medications: 1. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day) for 1 months. disp:*60 capsule(s)* refills:*0* 2. ranitidine hcl 150 mg tablet sig: one (1) tablet po bid (2 times a day) for 1 months. disp:*60 tablet(s)* refills:*0* 3. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 4. tramadol 50 mg tablet sig: one (1) tablet po q4-6h (every 4 to 6 hours) as needed. disp:*40 tablet(s)* refills:*0* 5. metoprolol tartrate 25 mg tablet sig: one (1) tablet po tid (3 times a day). disp:*90 tablet(s)* refills:*2* 6. furosemide 20 mg tablet sig: one (1) tablet po daily (daily) for 10 days. disp:*10 tablet(s)* refills:*0* 7. potassium chloride 10 meq tablet sustained release sig: one (1) tablet sustained release po once a day for 10 days. disp:*10 tablet sustained release(s)* refills:*0* 8. zocor 40 mg tablet sig: one (1) tablet po once a day. disp:*30 tablet(s)* refills:*0* 9. fosamax plus d 70-2,800 mg-unit tablet sig: one (1) tablet po once a week. disp:*30 tablet(s)* refills:*0* discharge disposition: home with service facility: home and health vna md procedure: single internal mammary-coronary artery bypass extracorporeal circulation auxiliary to open heart surgery (aorto)coronary bypass of two coronary arteries diagnoses: coronary atherosclerosis of native coronary artery intermediate coronary syndrome pure hypercholesterolemia unspecified essential hypertension cardiac complications, not elsewhere classified atrial fibrillation osteoporosis, unspecified 

Answer: The patient is high likely exposed to